DreaMed Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Mezzanine

  • Investors
  • 9

DreaMed General Information

Description

Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses event-driven machine learning and logic technology to process multiple personalized parameters such as insulin delivery data, glucose readings, meal data, and optimized insulin dosing treatment plans, enabling clients to improve their living standards and lower their overall treatment costs.

Contact Information

Website
dreamed.ai
Formerly Known As
Advisor Pro
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 14 Kaplan street the Endocrinology Center
  • Schneider Childrens Medical Center
  • Petah Tikva 4920235
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DreaMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Mezzanine 15-Feb-2022 00.000 Completed Generating Revenue
4. Early Stage VC 18-Sep-2017 00.000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Jul-2016 00.00 00.00 000.00 Completed Generating Revenue
2. Grant 03-Feb-2016 $3.4M $2M Completed Generating Revenue
1. Angel (individual) 06-Apr-2015 $2M $2M 000.00 Completed Generating Revenue
To view DreaMed’s complete valuation and funding history, request access »

DreaMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses even
Monitoring Equipment
Petah Tikva, Israel
28 As of 2024
00.000
000000000000 00.000

000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000000 000000000
London, United Kingdom
0 As of 0000
00.000 0000-00-00
000000&0

0000 0

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor in
0000000000 000000000
Fremont, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DreaMed Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlucoWise Formerly Accelerator/Incubator backed London, United Kingdom 0 000000&0
POGO Automatic Private Equity-Backed Fremont, CA 00 00000 000000000 00000
GlySens Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
DexCom Formerly VC-backed San Diego, CA 0000 00000 000000000 00000
Ascensia Diabetes Care Formerly PE-Backed Basel, Switzerland 0000 000000000000
You’re viewing 5 of 13 competitors. Get the full list »

DreaMed Patents

DreaMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210193285-A1 A system and method for use in disease treatment management Inactive 19-Oct-2017 000000000 0
US-8954373-B2 Monitoring device for management of insulin delivery Active 30-Sep-2009 00
US-20150134356-A1 Monitoring device for management of insulin delivery Active 30-Sep-2009
CA-2776007-A1 Monitoring device for mangement of insulin delivery Inactive 30-Sep-2009 000000000
EP-2483824-A1 Monitoring device for mangement of insulin delivery Active 30-Sep-2009 G16H20/17
To view DreaMed’s complete patent history, request access »

DreaMed Executive Team (14)

Name Title Board Seat
Eran Atlas Co-Founder, Chief Executive Officer & Board Member
Yael Shtrit Chief Operating Officer
Ido Muller Co-founder & Director of Algorithm and Data Analysis Department
Revital Nimri Co-Founder, Chief Medical R&D Officer & Clinical Advisor
Tadej Battelino Co-Founder & Clinical Advisory Board Member
You’re viewing 5 of 14 executive team members. Get the full list »

DreaMed Board Members (4)

Name Representing Role Since
Eran Atlas DreaMed Co-Founder, Chief Executive Officer & Board Member 000 0000
Kinneret Livnat Savitzky Ph.D Self Board Member 000 0000
Moshe Phillip Self Co-Founder, Chief Scientific Officer & Chairman 000 0000
Shay Marcus Self Board Member 000 0000
To view DreaMed’s complete board members history, request access »

DreaMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DreaMed Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
A-Labs Corporation Minority 000 0000 000000 0
Mark Suss Angel (individual) Minority 000 0000 000000 0
OurCrowd Venture Capital Minority 000 0000 000000 0
StartUp Health Venture Capital Minority 000 0000 000000 0
The Millhouse Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

DreaMed FAQs

  • When was DreaMed founded?

    DreaMed was founded in 2014.

  • Who is the founder of DreaMed?

    Eran Atlas, Shahar Miller, Ido Muller, Revital Nimri, Aviel Fogel, Tadej Battelino, Moshe Phillip, and Thomas Danne are the founders of DreaMed.

  • Who is the CEO of DreaMed?

    Eran Atlas is the CEO of DreaMed.

  • Where is DreaMed headquartered?

    DreaMed is headquartered in Petah Tikva, Israel.

  • What is the size of DreaMed?

    DreaMed has 28 total employees.

  • What industry is DreaMed in?

    DreaMed’s primary industry is Monitoring Equipment.

  • Is DreaMed a private or public company?

    DreaMed is a Private company.

  • What is DreaMed’s current revenue?

    The current revenue for DreaMed is 00000.

  • How much funding has DreaMed raised over time?

    DreaMed has raised $6.51M.

  • Who are DreaMed’s investors?

    A-Labs, Mark Suss, OurCrowd, StartUp Health, and The Millhouse are 5 of 9 investors who have invested in DreaMed.

  • Who are DreaMed’s competitors?

    GlucoWise, POGO Automatic, GlySens, DexCom, and Ascensia Diabetes Care are some of the 13 competitors of DreaMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »